A mass tort and a class action are both legal mechanisms for groups of people to sue the same defendant, but they differ in one fundamental way: in a mass tort, each plaintiff is treated as an individual with a separate case, while in a class action, all plaintiffs are lumped together as a single unified group represented by one or a few named class representatives. This distinction affects everything from how much compensation you receive to how much control you have over your own case. Someone injured by a defective hip implant, for example, might file as part of a mass tort because the severity of their injury, their medical costs, and their lost wages are unique to them and deserve individual evaluation. A consumer overcharged by a deceptive billing practice, on the other hand, might join a class action because the harm is essentially the same for everyone. This difference is not just academic.
It determines whether you get a personalized settlement based on your actual damages or a small check from a divided settlement fund. It shapes whether you can fire your lawyer, reject a settlement offer, or take your individual case to trial. And it dictates the legal procedures that govern your lawsuit from start to finish. This article breaks down every major distinction between mass torts and class actions, from court certification requirements and compensation structures to the types of cases where each approach is most commonly used. We will also look at current mass tort statistics from 2026 to give you a sense of how large these cases have become.
Table of Contents
- What Makes a Mass Tort Legally Different From a Class Action Lawsuit?
- How Compensation Differs and Why It Matters for Your Payout
- Control Over Your Own Case and Attorney Relationship
- When a Mass Tort Makes More Sense Than a Class Action
- The Scale of Mass Tort Litigation in 2026
- How Cases Get Consolidated and What That Means for You
- The Future of Mass Torts and Class Actions
- Conclusion
- Frequently Asked Questions
What Makes a Mass Tort Legally Different From a Class Action Lawsuit?
The clearest legal distinction comes down to certification and court procedure. Class actions must be certified under Federal Rule of Civil Procedure 23, which imposes four strict prerequisites: numerosity (courts generally look for at least 40 members), commonality (shared legal or factual questions), typicality (the named plaintiff’s claims must be typical of the class), and adequacy of representation (the representative must fairly protect the class’s interests). On top of that, the class must satisfy one of the Rule 23(b) categories, such as demonstrating that common questions predominate over individual ones. If a court denies certification, the class action cannot proceed as a group lawsuit. mass torts do not require this kind of formal class certification at all. Instead, when multiple individual lawsuits arise from the same product or event, federal cases are typically consolidated into Multidistrict Litigation, or MDL, for pretrial efficiency.
An MDL allows a single judge to handle discovery, motions, and other pretrial matters for hundreds or thousands of cases at once, but each case retains its individual identity. No one needs to prove that every plaintiff’s situation is “typical” of the group, because the whole point is that each person’s injuries and circumstances are different. This is why mass torts are the preferred vehicle for cases involving defective drugs or medical devices, where one person might have suffered organ failure while another experienced only mild side effects. A practical example: the Johnson & Johnson talcum powder litigation is a mass tort with roughly 67,600 pending cases as of January 2026. Each plaintiff alleges that talc-based products caused their cancer, but their diagnoses, treatment histories, and damages vary enormously. A class action structure would be unworkable here because no single plaintiff could adequately represent the range of injuries involved.
How Compensation Differs and Why It Matters for Your Payout
The compensation structure is where mass torts and class actions diverge most dramatically for the people involved. In a mass tort, settlements are negotiated individually or in tiers based on injury severity. A plaintiff who underwent multiple surgeries and lost the ability to work will receive significantly more than someone whose injuries were less severe. Each person’s award reflects their unique medical costs, lost wages, pain and suffering, and other personal damages. This individualized approach means the process takes longer and requires more legal work, but the payouts tend to be substantially larger. In a class action, a single settlement fund is established and then distributed among all class members, often equally or according to a formula. This structure works well when everyone suffered roughly the same harm, like being charged the same hidden fee, but it frequently results in small per-person amounts.
You have probably received one of those class action settlement checks for $3.47. That is not a flaw in the system so much as a feature of how class actions distribute a finite pool of money across thousands or millions of people. The Equifax data breach settlement, for instance, was initially touted as offering $125 per person, but so many people filed claims that individual payouts were far less. However, there is an important caveat. Mass tort compensation is not guaranteed to be higher just because cases are treated individually. If your injuries are relatively minor, or if your evidence linking the defendant’s product to your harm is weak, you may end up with less than you would have received from a class action settlement fund. The individualized approach cuts both ways. It rewards severe injuries generously but offers no floor for lesser claims.
Control Over Your Own Case and Attorney Relationship
One of the most significant practical differences is how much control you retain over your own legal decisions. In a mass tort, each plaintiff maintains a direct attorney-client relationship with their own lawyer. You can individually decide whether to accept a settlement offer, proceed to trial, or withdraw from the litigation entirely. Your choices do not bind anyone else, and no one else’s choices bind you. If your attorney presents a settlement offer you find inadequate, you can reject it and pursue other options without affecting the thousands of other plaintiffs in the same MDL. Class action members have far less autonomy. Once a court certifies a class, the class representative and class counsel make decisions on behalf of the entire group.
If the class representative agrees to a settlement, that settlement applies to every class member unless they formally opt out. The opt-out process itself has deadlines, and many people miss them because they did not read the notice carefully or did not realize they were part of the class at all. You are essentially placing your legal fate in the hands of someone you have never met and a law firm you did not hire. Consider the Camp Lejeune water contamination litigation as an example of mass tort control in action. Each veteran or family member who was exposed to contaminated water at the base files an individual claim. Some plaintiffs have settled, while others continue to litigate. A family that lost a member to cancer linked to the contamination pursues a very different claim than someone who developed a skin condition. The mass tort framework allows each of these plaintiffs to make independent decisions that reflect the gravity of their own situation.
When a Mass Tort Makes More Sense Than a Class Action
Choosing between these two legal vehicles is not always up to the plaintiffs. Courts and attorneys evaluate the nature of the harm to determine which approach fits. Mass torts are most appropriate when injuries vary widely in type and severity. Defective drugs, defective medical devices, toxic chemical exposure, and product liability cases where each plaintiff’s health outcome is different from the next are the bread and butter of mass tort litigation. The hernia mesh MDL, with approximately 24,000 pending cases, is a prime example. Some patients had their mesh devices removed successfully with minimal long-term effects. Others suffered chronic pain, infections, organ perforation, or required multiple revision surgeries.
Treating these plaintiffs identically would be unjust. Class actions, by contrast, are the better fit when harm is relatively uniform across plaintiffs. Consumer protection violations, data breaches, employment discrimination, securities fraud, and antitrust claims are the most common class action scenarios. If a company overcharged every customer by the same percentage, or if every employee was subject to the same discriminatory policy, the class action mechanism efficiently resolves thousands of identical claims in one proceeding. The tradeoff is clear: class actions sacrifice individualized justice for efficiency, while mass torts sacrifice efficiency for individualized justice. The wrinkle is that some cases start as attempted class actions and get reclassified. If a court finds that individual issues predominate over common ones, it may deny class certification, pushing plaintiffs toward individual lawsuits or mass tort consolidation instead. This happened in some early attempts to certify classes in pharmaceutical injury cases, where courts recognized that each plaintiff’s medical history, dosage, and reaction were too varied for class treatment.
The Scale of Mass Tort Litigation in 2026
The sheer volume of mass tort cases in the federal system gives some sense of how significant this area of law has become. As of January 2026, there are approximately 198,000 pending cases across federal MDLs, with 342,000 total cases filed. These numbers reflect not just the prevalence of mass torts but also the expanding categories of products and chemicals that generate large-scale litigation. The largest active MDLs by pending case count tell a revealing story. Johnson & Johnson’s talcum powder litigation leads with roughly 67,600 pending cases. Hernia mesh cases account for about 24,000. The AFFF and PFAS firefighting foam litigation has approximately 15,216 pending cases, a figure that jumped 99 percent since January 2025, reflecting growing awareness of forever chemical contamination.
Roundup glyphosate herbicide cases number around 4,500 pending as of February 2026. And the newer GLP-1 medication litigation, involving drugs like Ozempic, has already reached 2,947 lawsuits filed with more than 1,600 pending in its MDL. A warning worth noting: the existence of a large MDL does not guarantee that your individual case has merit or that settlements are imminent. Some MDLs drag on for years. Bellwether trials, which are test cases used to gauge how juries might respond, can produce mixed results that complicate settlement negotiations. The AFFF litigation, for instance, has seen significant movement in some tracks but remains unresolved for many individual plaintiffs. Filing a claim in a mass tort is the beginning of what may be a lengthy process, not a fast track to compensation.
How Cases Get Consolidated and What That Means for You
When hundreds or thousands of people file individual lawsuits against the same defendant in different federal courts, the Judicial Panel on Multidistrict Litigation can transfer those cases to a single district court for coordinated pretrial proceedings. This is the MDL process, and it is distinct from a class action in a critical way: your case is consolidated only for efficiency during the pretrial phase. Once pretrial matters are resolved, cases that do not settle can theoretically be sent back to their original courts for individual trials. In practice, the vast majority of MDL cases settle before reaching that point.
Bellwether trials serve as a barometer. If defendants lose several bellwether cases with large verdicts, they have strong incentive to negotiate a global settlement. If plaintiffs lose, settlement values may drop, and some law firms may advise their clients to accept lower offers. The 3M earplug litigation demonstrated both dynamics. After a string of plaintiff verdicts totaling billions, 3M ultimately moved toward a large-scale settlement, but the path there took years and dozens of individual trials.
The Future of Mass Torts and Class Actions
Both mass torts and class actions are evolving in response to new categories of harm. The rapid growth of the AFFF/PFAS litigation and the emergence of GLP-1 medication lawsuits show that mass torts are expanding beyond traditional pharmaceutical and device cases into environmental contamination and newer drug categories. Meanwhile, class actions continue to be a primary vehicle for data breach and consumer privacy claims, an area that shows no sign of slowing down as companies collect and lose personal data at scale.
One trend worth watching is the increasing use of litigation funding and large-scale plaintiff recruitment, which has made mass torts more accessible but has also drawn scrutiny from courts and defendants. The balance between ensuring injured people can access justice and preventing the system from being overwhelmed by unvetted claims will likely shape procedural reforms in the coming years. For anyone currently weighing whether to join a mass tort or a class action, the core question remains the same: is your injury unique enough to warrant individual treatment, or is it substantially identical to everyone else’s?.
Conclusion
The difference between a mass tort and a class action comes down to individuality versus efficiency. Mass torts treat each plaintiff as a separate case with unique injuries and damages, allow each person to retain control over their legal decisions, and typically produce larger but more variable payouts. Class actions group everyone together under shared representation, apply a single settlement to the entire class, and prioritize resolving large numbers of similar claims quickly. Neither approach is inherently better.
The right one depends on the nature of the harm and how much variation exists among the people affected. If you believe you have been injured by a defective product, dangerous drug, or toxic exposure, the first step is consulting an attorney who handles mass tort cases to evaluate whether your claim has individual merit. If your situation involves a uniform harm like a billing overcharge or data breach, a class action may already exist that you can join. In either case, understanding how each mechanism works puts you in a better position to make informed decisions about your legal options rather than simply waiting for a check in the mail.
Frequently Asked Questions
Can a lawsuit be both a mass tort and a class action?
No, they are distinct legal procedures. However, some litigation starts as an attempted class action and shifts to mass tort treatment if a court finds that individual issues predominate. The reverse can also happen if a court determines that claims are sufficiently uniform.
Do I need my own lawyer for a mass tort?
Yes. Each plaintiff in a mass tort has their own attorney-client relationship. While lead counsel may be appointed to handle pretrial matters in an MDL, your individual attorney represents your specific interests and advises you on settlement decisions.
How long does a mass tort take compared to a class action?
Mass torts generally take longer because each case requires individual evaluation. Complex mass torts like the talcum powder litigation have been ongoing for years. Class actions can also be lengthy, but they tend to resolve more quickly once a settlement is reached because a single agreement covers the entire class.
Will I get more money from a mass tort than a class action?
It depends on the severity of your injuries. Mass tort plaintiffs with serious injuries typically receive significantly more than class action members because compensation reflects individual damages. However, plaintiffs with minor injuries in a mass tort may receive less than they would from a class action settlement fund.
What does it cost to join a mass tort?
Most mass tort attorneys work on a contingency fee basis, meaning you pay nothing upfront. The attorney takes a percentage of your settlement or verdict, typically between 33 and 40 percent. If you recover nothing, you owe nothing in legal fees.
Can I opt out of a class action and file my own lawsuit?
In most cases, yes. When a class action is certified, members receive notice and a deadline to opt out. If you opt out, you can file an individual lawsuit, but you will need to prove your case on your own. Missing the opt-out deadline generally means you are bound by whatever the class settlement provides.